Filing Flows › Comparisons › ULS vs AIDX
UL Solutions vs 20/20 Biolabs: ULS and AIDX compared
UL Solutions is the larger company: $823M of revenue in its latest quarter (Q3 2026) against $731K for 20/20 Biolabs (Q2 2026). 20/20 Biolabs is growing faster (+36% against +5% a year earlier). UL Solutions is more profitable, with an operating margin of 19.7% against -170.3%.
Where the money goes: ULS and AIDX
UL Solutions (ULS) · Q3 2026
UL Solutions, Q3 2026: revenue $823M (+5% year over year), operating margin 19.7%, net earnings $108M, operating cash flow $215M. The chart follows the revenue to costs, profit and cash.
20/20 Biolabs (AIDX) · Q2 2026
20/20 Biolabs, Q2 2026: revenue $731K (+36% year over year), operating margin -170.3%, net loss $1.5M, operating cash flow −$605K. The chart follows the revenue to costs, profit and cash.
| UL Solutions (ULS) | 20/20 Biolabs (AIDX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $823M | $731K |
| Revenue growth, Y/Y | +5% | +36% |
| Operating margin | 19.7% | -170.3% |
| Net earnings | $108M | −$1.5M |
| Net margin | 13.1% | -206.2% |
| Operating cash flow | $215M | −$605K |
| Free cash flow | $154M | — |
| Market value | $16.0B | — |
| P/E | 31.2× | — |
| Analysts’ mean target | $97.20 | — |
Where the revenue comes from
UL Solutions
- Ongoing Certification Services: $270M (33%)
- Certification Testing: $248M (30%)
- Non-certification Testing and Other Services: $244M (30%)
- Software: $61.0M (7%)
20/20 Biolabs
- OneTest: $696K (95%)
- BioCheck: $35K (5%)
Questions
Which is bigger, UL Solutions or 20/20 Biolabs?
UL Solutions is the larger company: $823M of revenue in its latest quarter (Q3 2026) against $731K for 20/20 Biolabs (Q2 2026).
Is UL Solutions or 20/20 Biolabs growing faster?
20/20 Biolabs is growing faster (+36% against +5% a year earlier).
Which is more profitable, UL Solutions or 20/20 Biolabs?
UL Solutions is more profitable, with an operating margin of 19.7% against -170.3%.
More: UL Solutions earnings · how UL Solutions makes money · 20/20 Biolabs earnings · how 20/20 Biolabs makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.